Aecom vs Ginkgo Bioworks Holdings Inc — how do they compare? Aecom trades at $67.13 (market cap $8.62B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Aecom is far larger — about 17× Ginkgo Bioworks Holdings Inc's market cap, and Aecom pays a 1.77% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| ACM | DNA | |
|---|---|---|
Market Cap | $8.62B | $505.73M |
Sector | Industrials | Health |
52-Week High | $134.35 | $16.14 |
52-Week Low | $66.86 | $5.48 |
Enterprise Value | $10.81B | $607.68M |
Dividend Yield | 1.77% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ginkgo Bioworks (DNA) trades at $7.97, down 6.24% today, reflecting ongoing operational challenges. The company reported Q2 2026 revenue of $20 million, a 48% year-over-year decline, as it shifts focus to autonomous lab systems. Despite beating EPS expectations in two of the last three quarters, net losses remain substantial with a -219.6% margin. Technical indicators show bearish momentum with support at $7 and resistance at $9.
DNA faces significant headwinds with declining revenue and persistent losses, though analyst sentiment is mixed with 45% buy ratings. The pivot to new business lines creates uncertainty, while cash burn and competitive pressures present substantial risks. Upside depends on successful execution of the strategic shift and path to profitability.
Trailing returns across standard periods
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →